Warning! GuruFocus detected
1 Severe warning sign
with BDRX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Biodexa Pharmaceuticals PLC
ISIN : US59564R1041
Share Class Description:
BDRX: ADRDescription
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.3 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 9.9 | |||||
| 3-Year FCF Growth Rate | -15.3 | |||||
| 3-Year Book Growth Rate | -10.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 44.41 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.76 | |||||
| 9-Day RSI | 50.27 | |||||
| 14-Day RSI | 44.22 | |||||
| 3-1 Month Momentum % | -61.38 | |||||
| 6-1 Month Momentum % | -73.54 | |||||
| 12-1 Month Momentum % | -90.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.75 | |||||
| Quick Ratio | 1.75 | |||||
| Cash Ratio | 0.33 | |||||
| Days Payable | 60.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.2 | |||||
| Shareholder Yield % | -222.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -79.1 | |||||
| ROA % | -43.74 | |||||
| ROIC % | -97.39 | |||||
| 3-Year ROIIC % | -27.87 | |||||
| ROC (Joel Greenblatt) % | -430.99 | |||||
| ROCE % | -69.2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.5 | |||||
| Price-to-Tangible-Book | 1.5 | |||||
| EV-to-EBIT | -0.38 | |||||
| EV-to-EBITDA | -0.4 | |||||
| EV-to-FCF | 0.15 | |||||
| Price-to-GF-Value | 0.02 | |||||
| Price-to-Net-Current-Asset-Value | 1.5 | |||||
| Earnings Yield (Greenblatt) % | -263.16 | |||||
| FCF Yield % | -413.95 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BDRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biodexa Pharmaceuticals PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -17.301 | ||
| Beta | 1.21 | ||
| 3-Year Sharpe Ratio | -2.71 | ||
| 3-Year Sortino Ratio | -2.26 | ||
| Volatility % | 66.82 | ||
| 14-Day RSI | 44.22 | ||
| 14-Day ATR ($) | 0.263388 | ||
| 20-Day SMA ($) | 1.4705 | ||
| 12-1 Month Momentum % | -90.67 | ||
| 52-Week Range ($) | 1.14 - 73.9975 | ||
| Shares Outstanding (Mil) | 2.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biodexa Pharmaceuticals PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biodexa Pharmaceuticals PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biodexa Pharmaceuticals PLC Frequently Asked Questions
What is Biodexa Pharmaceuticals PLC(BDRX)'s stock price today?
The current price of BDRX is $1.56. The 52 week high of BDRX is $74.00 and 52 week low is $1.14.
When is next earnings date of Biodexa Pharmaceuticals PLC(BDRX)?
The next earnings date of Biodexa Pharmaceuticals PLC(BDRX) is 2025-08-15 Est..
Does Biodexa Pharmaceuticals PLC(BDRX) pay dividends? If so, how much?
Biodexa Pharmaceuticals PLC(BDRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers